Abstract
Hyaluronic acid (HA) is widely used to treat various ocular diseases like dry eye syndrome, keratoconus, and other corneal epithelial injuries. The currently available eye drop solutions need frequent doses affecting the routine life style of patients. In this work, the silicone contact lens was designed to entrap HA and Pluronic®F127 to improve the wettability of the contact lens to treat various ocular diseases. The soaking method (HA-SM) was compared with the direct entrapment (DL-HA-PI) technique. The HA-Pluronic®F127-laden contact lenses (DL-HA-PI) showed acceptable optical transmittance with improved swelling (water content) properties. The in vitro release data showed high burst release with HA-SM contact lenses (12–36 h), while DL-HA-PI contact lenses showed prolong release up to 96 h. The in vivo release in the rabbit tear fluid showed high HA concentration (tear fluid) with DL-HA-PI contact lenses in comparison to the HA-SM contact lenses. The DL-HA-PI-3 batch with Pluronic®F127 showed more promising results in schirmer strip study in comparison to DL-HA-3 batch (without Pluronic®F127). The presence of Pluronic®F127 with HA showed high potential to improve hydration property of the contact lens. The corneal healing model showed reduction in the ocular inflammatory symptoms with DL-HA-PI-3 batch, thus demonstrating the potential of HA and Pluronic®F127 to be used in various ocular diseases.
Similar content being viewed by others
Change history
26 August 2022
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1208/s12249-022-02400-y
References
Tani E, Katakami C, Negi A. Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits. Jpn J Ophthalmol. 2002;46(5):488–95.
Gomes J, Amankwah R, Powell-Richards A, Dua H. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004;88(6):821–5.
Bata AM, Witkowska KJ, Wozniak PA, Fondi K, Schmidinger G, Pircher N, et al. Effect of a matrix therapy agent on corneal epithelial healing after standard collagen cross-linking in patients with keratoconus: a randomized clinical trial. JAMA Ophthalmology. 2016;134(10):1169–76.
Limberg MB, McCaa C, Kissling GE, Kaufman HE. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes. Am J Ophthalmol. 1987;103(2):194–7.
Bachu RD, Chowdhury P, Al-Saedi ZH, Karla PK, Boddu SH. Ocular drug delivery barriers—role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1):28–35.
A. Desai, M. Shukla, F. Maulvi, K. Ranch, Ophthalmic and otic drug administration: novel approaches and challenges, Novel Drug Delivery Technologies, Springer2019, pp. 335–381.
Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131–5.
Ding S. Recent developments in ophthalmic drug delivery. Pharmaceut Sci Tech Today. 1998;1(8):328–35.
Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016;10:2433–41.
H.J.J.o.d.t. Chen, Recent developments in ocular drug delivery, Journal of drug targeting 23(7–8) (2015) 597–604.
Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 2004;269(1):1–14.
Cholkar K, Patel SP, Vadlapudi AD, Mitra AK. Novel strategies for anterior segment ocular drug delivery. J Ocul Pharmacol Ther. 2013;29(2):106–23.
Davis J, Gilger B, Robinson M. Novel approaches to ocular drug delivery. Curr Opin Mol Ther. 2004;6(2):195–205.
K. Cholkar, A. Patel, A. Dutt Vadlapudi, A. K Mitra, Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery, Recent patents on nanomedicine 2(2) (2012) 82–95.
Maulvi FA, Thakkar VT, Soni TG, Gandhi TR, Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation, Current drug delivery 11(3) (2014) 380–391.
Pandey S, Swamy SV, Gupta A, Koli A, Patel S, Maulvi F, et al. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. J Microencapsul. 2018;35(3):259–71.
Maulvi FA, Bodaa AM, Desai AR, Choksi HH, Ranch KM, Shah DO. Application of box-Behnken design in optimization of ibuprofen ternary solid dispersion. J Pharm Appl Sci. 2015;2(2):1–11.
Zhang X, Cao X, Qi P. Therapeutic contact lenses for ophthalmic drug delivery: major challenges. J Biomater Sci, Polymer Edition (just-accepted). 2020:1–16.
Singh A, Li P, Beachley V, McDonnell P, Elisseeff JH. A hyaluronic acid-binding contact lens with enhanced water retention. Contact Lens Anterior Eye. 2015;38(2):79–84.
Van Beek M, Jones L, Sheardown H. Hyaluronic acid containing hydrogels for the reduction of protein adsorption. Biomaterials. 2008;29(7):780–9.
George M, Khong K, Maltseva I. Hyaluronic acid (HA) release of HA-containing lens care solutions with silicone hydrogel lenses. Contact Lens Anterior Eye. 2019;42(6):e17–8.
Maulvi FA, Singhania SS, Desai AR, Shukla MR, Tannk AS, Ranch KM, et al. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis. Int J Pharm. 2018;548(1):139–50.
Liu Y, Ren L, Wang Y. Crosslinked collagen–gelatin–hyaluronic acid biomimetic film for cornea tissue engineering applications. Mater Sci Eng C. 2013;33(1):196–201.
Fiorica C, Palumbo FS, Pitarresi G, Bongiovì F, Giammona G. Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone. Carbohydr Polym. 2017;166:281–90.
Fiorica C, Senior RA, Pitarresi G, Palumbo FS, Giammona G, Deshpande P, et al. Biocompatible hydrogels based on hyaluronic acid cross-linked with a polyaspartamide derivative as delivery systems for epithelial limbal cells. Int J Pharm. 2011;414(1–2):104–11.
Maulvi FA, Parmar RJ, Desai AR, Desai DM, Shukla MR, Ranch KM, et al. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: addressing the issue of transmittance and swelling. Int J Pharm. 2020;119279.
Desai AR, Maulvi FA, Desai DM, Shukla MR, Ranch KM, Vyas BA, et al. Multiple drug delivery from the drug-implants-laden silicone contact lens: addressing the issue of burst drug release. Mater Sci Eng C. 2020;110885.
Maulvi FA, Parmar RJ, Shukla MR, Desai AR, Desai DT, Ranch KM, et al. Plackett-Burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-Pluronic-loaded contact lens. Int J Pharm. 2019;566:513–9.
Kim T-H, Yae K-H, Kweon Y-S, Sung A. Study on the silicone contact lens using AA and BMA. J Korean Ophthalmic Opt Soc. 2006;11(3):259–65.
Polse K, Decker M. Oxygen tension under a contact lens. Invest Ophthalmol Vis Sci. 1979;18(2):188–93.
Moore L, Ferreira JT. Ultraviolet (UV) transmittance characteristics of daily disposable and silicone hydrogel contact lenses. Contact Lens Anterior Eye. 2006;29(3):115–22.
Harris MG, Chin RS, Lee DS, Tam MH, Dobkins CE. Ultraviolet transmittance of the Vistakon disposable contact lenses. Contact Lens Anterior Eye. 2000;23(1):10–5.
A. THAKUR, M.D.J.E.e.r. WILLCOX, Contact lens wear alters the production of certain inflammatory mediators in tears, 70(3) (2000) 255–259.
Sack RA, Sathe S, Hackworth LA, Willcox MD, Holden BA, Morris CA. The effect of eye closure on protein and complement deposition on group IV hydrogel contact lenses: relationship to tear flow dynamics. Curr Eye Res. 1996;15(11):1092–100.
Ciolino JB, Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials. 2014;35(1):432–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1208/s12249-022-02400-y
Electronic supplementary material
ESM 1
(DOCX 1127 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wei, N., Xu, X., Huang, C. et al. RETRACTED ARTICLE: Hyaluronic Acid-Pluronic®F127-Laden Soft Contact Lenses for Corneal Epithelial Healing: In Vitro and In Vivo Studies. AAPS PharmSciTech 21, 162 (2020). https://doi.org/10.1208/s12249-020-01714-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-020-01714-z